삼진제약: insider trades · South Korea · DART (FSS)

Discover the full directors' dealings record of 삼진제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Market capitalisation: €242.1bn. The latest transaction was filed on 15 April 2026 — Purchase. Among the most active insiders: 박창익. Every trade is accessible without an account.